TY  - GEN
AU  - Liu,Anthony P Y
AU  - Hastings,Camden
AU  - Wu,Shengjie
AU  - Bass,Johnnie K
AU  - Heitzer,Andrew M
AU  - Ashford,Jason
AU  - Vestal,Robert
AU  - Hoehn,Mary E
AU  - Ghazwani,Yahya
AU  - Acharya,Sahaja
AU  - Conklin,Heather M
AU  - Boop,Frederick
AU  - Merchant,Thomas E
AU  - Gajjar,Amar
AU  - Qaddoumi,Ibrahim
TI  - Treatment burden and long-term health deficits of patients with low-grade gliomas or glioneuronal tumors diagnosed during the first year of life
SN  - 1097-0142
PY  - 2019///1230
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Brain Neoplasms
KW  - pathology
KW  - Cell Transformation, Neoplastic
KW  - Cerebrovascular Disorders
KW  - epidemiology
KW  - Cost of Illness
KW  - Endocrine System Diseases
KW  - Female
KW  - Follow-Up Studies
KW  - Glioma
KW  - Hearing Loss
KW  - Humans
KW  - Infant
KW  - Infant, Newborn
KW  - Long Term Adverse Effects
KW  - Male
KW  - Neoplasm Grading
KW  - Neurocognitive Disorders
KW  - Neurosurgical Procedures
KW  - Obesity
KW  - Progression-Free Survival
KW  - Radiotherapy
KW  - Retrospective Studies
KW  - Scoliosis
KW  - Seizures
KW  - Spinal Cord Neoplasms
KW  - Survival Rate
KW  - Vision Disorders
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/cncr.31918
ER  -